Full Text View
Tabular View
No Study Results Posted
Related Studies
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00989586   Information provided by Ohio State University Comprehensive Cancer Center

First Received on October 2, 2009.   Last Updated on September 28, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial